We investigated the effects of neuromuscular blockade with atracurium on oxygen consumption, oxygen delivery and total chest compliance in 20 sedated intensive care patients who required mechanical ventilation with an inspired oxygen fraction of at least 0.6.
Neuromuscular blocking agents (NMBA) may be used in the intensive care unit in mechanically ventilated patients when other methods of optimizing oxygenation have failed 1 . The reported indications include facilitation of mechanical ventilation and the reduction of oxygen consumption (VO 2 ) 2-5 . In patients with critical oxygenation requiring high levels of inspired oxygen, it has been proposed that neuromuscular blockade reduces oxygen consumption by minimizing muscle activity and tone. Neuromuscular blockade may also improve oxygenation by increasing total thoracic compliance (Ct) thereby permitting more effective ventilation of the lungs.
The problems of long-term use of NMBA are well documented and can include prolonged neuromuscular weakness syndrome [6] [7] [8] . This is more commonly associated with the amino-steroid muscle relaxants pancuronium and vecuronium but has also been described in association with atracurium and cisatracurium 9, 10 . Keeping the patient still and limiting oxygen consumption may often be achieved by the correct use of sedation, in which case the use of nondepolarizing muscle relaxants may be avoided. It has been demonstrated that sedation levels are closely correlated with oxygen consumption in postoperative patients 11 . The aim of our study was to assess whether the administration of atracurium influenced the oxygen delivery (DO 2 ) or consumption (VO 2 ) in critically ill patients requiring an F i O 2 greater than 0.6 who were adequately sedated. We included neuromuscular monitoring and sedation scores.
METHODS
Ethics Committee approval was obtained, and fully informed written consent was obtained from the patients' relatives. We recruited 20 adult intensive care patients who were mechanically ventilated and required an F i O 2 greater than 0.6 to maintain a P a O 2 greater than 75 mmHg (10 kPa), i.e. an alveolararterial difference of greater than 50 kPa. The patients had an indwelling pulmonary artery flotation catheter (Baxter Swan-Ganz ® Baxter Healthcare Corporation, Irvine, CA) and an arterial cannula. The patients demonstrated a level of sedation such that there was no response to stimulation, no spontaneous movement and no respiratory effort other than coughing on suction (Ramsey score 5) 5 . All patients received pressure controlled ventilation with positive end expiratory pressure (PEEP) of 5-11 cm H 2 O (mean 6.7) with an inspiratory: expiratory (I:E) ratio of 1:1 or with an inverse ratio. The ventilators used were the Puritan Bennett 7200 (Puritan Bennett Corporation, Carlsbad, CA) and the Drager Evita 2 (Dragerwerk, Germany).
Baseline measurements were made of the cardiac output, heart rate, mean arterial pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, systemic vascular resistance, pulmonary vascular resistance (Spacelab Monitoring Systems, Spacelab Medical Inc. Redmond, WA), arterial oxygen content, arterial saturation, mixed venous saturation (SvO 2 )(direct analysis, i.e. co-oximetry) (AVL Omni ® AVL Medical division, Graz, Austria) and total thoracic compliance. These were made at time T0.
We used thermodilution to measure the cardiac output, the temperature of the injectate was below 8°C and we used the mean of three measures with a value within 10% of each other. Oxygen consumption was measured by the reverse Fick method. We estimated dynamic thoracic compliance by measuring the tidal volume, the plateau airway pressure and the level of PEEP as indicated by the ventilator pressure transducer and pneumotachograph.
At time zero, a bolus of atracurium (0.4 mg.kg -1 ) was administered intravenously and further increments were given as necessary to achieve a satisfactory level of neuromuscular blockade.
We achieved a standard level of neuromuscular blockade of one train-of-four response in all patients. The degree of paralysis was assessed by the tactile assessment of the train-of-four ratio using a peripheral nerve stimulator (Microstim ®, Viamed, Keighley, U.K.). We repeated haemodynamic and respiratory measurements as soon as this level of paralysis was achieved. This was designated as time T1. Spontaneous recovery of neuromuscular function was permitted. Full return of muscle power was considered to be present when we could elicit no fade on double burst stimulation as assessed by tactile stimulation. To ensure that there was no residual blockade we waited a further ten minutes; at this stage we made another set of cardiac output studies and calculated the indices of oxygenation (T2).
Calculations
We used the following calculations in our analysis of data: Arterial oxygen content=(0.0138)(Hb)(SaO 2 )+ 0.0031(P a O 2 ) Venous oxygen content=(0.0138)(Hb)(
Oxygen delivery=C a O 2 (C0)(10) Compliance= tidal volume (litres) plateau airway pressure-PEEP pressure Statistical analysis was performed using paired t-tests (Excel spreadsheet, Microsoft version 7.0).
RESULTS
We analysed results from 20 intensive care patients fulfilling the admission criteria. Demographic data and patient characteristics are shown in Table 1 .
The DO 2 , VO 2 , and CO data for each individual patient are listed in Table 2 . The largest change was a mean fall in oxygen consumption of 7.7% after neuromuscular blockade. This failed to return to the baseline measurement with recovery of muscle function. Taking into account time related changes, we compared T1, the paralysed state, with the mean of T0 and T2. With this calculation the change in VO 2 showed a small fall of just 3.1% and DO 2 a fall of 3.3%. The standard deviations were high and none of the changes reached statistical significance (Student's t test P=0.24-0.92).
Eight of the patients demonstrated changes in VO 2 greater than the measurement error ( Figure 1 ): in five patients the VO 2 fell and in three patients the VO 2 increased.
There was no overall change in total compliance (Table 3 ). There was a fall in compliance of greater than 10% in three patients ( Figure 2 ). In two of these patients there was a subsequent rise in compliance towards the original value.
We calculated the measurement error for the Fick method by substituting the errors for the variables into the equation for oxygen consumption. Our measurement error was calculated to be 25 ml.min -1 (10%) for O 2 using the reverse Fick method. The inspired oxygen concentration did not change during the period of the study and the rate of vasoconstrictor and inotrope infusions remained the same. In all T0  T1  T2  T0  T1  T2  T0  T1  T2   1 Individual results for cardiac output (CO); oxygen delivery (DO); oxygen consumption (VO2) are presented. T0 is the measurement prior to paralysis; T1 is the measurement after neuromuscular blockade and T2 after return to normal neuromuscular function. The percentage change is expressed as a percentage change at T1 and T2 compared with the values at T0.
cases the duration of the study was less than 50 minutes.
DISCUSSION
It has been suggested that neuromuscular blockade may increase chest compliance and may decrease oxygen consumption by reducing muscle activity [2] [3] [4] [5] 12 .
Previous studies on this subject have been contradictory. A study of the effects of pancuronium 13 demonstrated a decrease in oxygen consumption after paralysis. However, the patients may have been poorly sedated prior to the administration of pancuronium. In addition, the cardiovascular effects of pancuronium may also have led to difficulties in the interpretation of the haemodynamic data: pancuronium is an indirect sympathomimetic and pro-duces pulmonary hypertension, which decreases hypoxic pulmonary vasoconstriction and may lead to increased venous admixture. In contrast, a study by Beards et al 14 found no change in oxygen delivery or consumption after a single bolus of pancuronium. Unfortunately no sedation scores were measured and the degree of neuromuscular blockade was not recorded. Both of these studies failed to continue measurements after the return of normal neuromuscular function. In the current study we remeasured the indices of oxygenation after the return of normal neuromuscular function. This was to minimize any errors due to changes that may have occurred during the period of study or as a result of our intervention. A recent study using a closed loop vecuronium infusion showed no change in oxygen consumption after paralysis but the degree of pulmonary dysfunction was less than in the current study 15 .
We used atracurium in our study because its metabolic profile is of advantage in patients with critical illness. Atracurium is metabolized by alkaline ester hydrolysis and Hofmann degradation, thereby avoiding renal and hepatic metabolism, which may be abnormal in the critically ill patient. It also has a low side-effect profile in the intensive care patient 16 . 195 Total thoracic compliance (l/cm H2O) for the patients during the three periods of the study are presented. T0, prior to paralysis; T1, after neuromuscular blockade; T2, after return to normal function. The compliance is shown in litres per centimetre of water. The percentage change are observed change from the initial value prior to commencement of the study(T0). The changes between T0 and T1 and the changes between T0 and T2 are demonstrated. {patient 9 incomplete because of technical problems} Sedation was standardized such that patients had no spontaneous movement and no response to stimuli other than coughing on tracheal aspiration. This ensured minimal muscle activity prior to paralysis to allow the best comparison of sedation with and without neuromuscular blockade. Our criteria for entry into the study included an F i O 2 greater than 0.6 to maintain a P a O 2 of greater than 75 mmHg (10 kPa). We calculated the oxygen consumption by the use of the reverse Fick method: calorimetry was avoided because it may be inaccurate in patients requiring an F i O 2 greater than 0.6 17, 18 .
Our results show no statistically significant change in mean oxygen consumption, delivery or total thoracic compliance as a result of neuromuscular blockade. We demonstrated a mean reduction of 3.1% in VO 2 in the paralysed state. Eight of the patients demonstrated changes in VO 2 greater than the measurement error. However, the direction of these changes was variable.
The changes in VO 2 mirrored the changes in DO 2 in all patients, probably due to mathematical coupling (correlation coefficient=0.87).
There was no significant change in mean total thoracic compliance: seven patients demonstrated a change of greater than 5%; in four of these there was a decrease in compliance. We could find no explanation for the decrease in compliance which was not associated with any change in oxygen consumption or delivery or cardiac output. There was no correlation between pathophysiology or the severity of respiratory disease and our findings. There are a number of possibilities why the compliance decreased in some patients including changes in lung volume or lung water, which warrant further study. Although there was no evident histamine release, and flows ceased during inspiration, changes in airway resistance could still have influenced our measured dynamic compliance.
A number of studies have shown that the achievement of oxygen delivery of greater than 600 ml.min -1 .m -2 is associated with improved outcome in specific groups of patients [19] [20] [21] [22] . It has also been demonstrated that oxygen debt is associated with the development of organ failure, sepsis and death in high-risk surgical patients 23 . Normally, oxygen consumption remains constant, but becomes limited below a critical threshold of delivery. It is essential therefore, that patients with sepsis or lung injury have optimal oxygen delivery.
Taking the groups as a whole, we were unable to demonstrate any statistically significant changes in the measured parameters but there were large changes in individual patients. The largest decrease in oxygen consumption was 35% and the largest increase was 17%. It was not possible to predict which patients would demonstrate favourable changes in parameters from neuromuscular blockade.
There are conflicting descriptions of the effect of achieving supranormal oxygen delivery on outcome in intensive care [1] [2] [3] [4] [5] . The nature of severe pulmonary pathology and sepsis implies that even normal oxygenation may be difficult to achieve. This may be due to altered respiratory mechanics, diffusion deficit or abnormal peripheral utilization of oxygen. It is a common assumption that the use of neuromuscular blocking agents will improve oxygenation by increasing chest compliance and that paralysis will cause a decrease in peripheral utilization of oxygen. However there are no reliable predictable changes, such that the administration of neuromuscular blocking agents in addition to adequate sedation confers no advantage. We have demonstrated that paralysis may even worsen compliance and oxygenation in selected patients. We suggest that should neuromuscular blockade be considered as an adjunct to therapy, indices of oxygenation should be measured.
